M. S. Goldberg, J. J. Siegel, K. Ahmed, S. J. Kurley, and A. S. Farberg, “A prospective clinical utility study demonstrates that physicians use the 40-gene expression profile (40-GEP) to guide clinical management decisions for Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC)”, J of Skin, vol. 6, no. 6, p. s95, Nov. 2022.